In the continuing search for newer pancreatic lipase inhibitors from plants, a total of 63 extracts from 21 different plants were screened to study their pancreatic lipase (PL) inhibitory activity in vitro. All three extracts (DCM, EtOAc and MeOH) of Murraya koenigii (L.) Spreng leaves (Rutaceae) exhibited antilipase activity greater than 80%. Further, bioactivity guided fractionation of the EtOAc extract led to the isolation of four alkaloids, namely mahanimbin, koenimbin, koenigicine and clausazoline-K, with IC 50 values of 17.9 µM, 168.6 µM, 428.6 µM and <500 µM, respectively. This study reports for the first time the PL inhibitory potential of carbazole alkaloids from plants.
Physiologically, obesity is a disarray of energy balance and is primarily considered as a disorder of lipid metabolism [1] . Because excess fat consumption is widely thought to be one of the main causes of obesity, means of specifically inhibiting triglyceride (TG) digestion have been developed as a new approach to reducing fat absorption. A growing number of enzymes involved in lipid metabolic pathways are being identified and characterized; as such they represent a rich pool of potential therapeutic targets for obesity [2] [3] [4] .
Pancreatic lipase (triacylgycerol acyl hydrolase), the principal lipolytic enzyme synthesized and secreted by the pancreas, plays a key role in the efficient digestion of triglycerides hydrolyzing 50-70% of dietary fats. Orlistat, one of the few drugs approved for antiobesity therapy, acts through inhibition of pancreatic lipase [5, 6] .
Many plants and their metabolites have earlier been reported to be inhibitors of pancreatic lipase and can form an important lead in the development of safe and effective antiobesity therapeutics. These inhibitors were recently reviewed by us [7, 8] .
In order to find newer pancreatic lipase (PL) inhibitors, 21 common medicinal plants were selected, through literature survey (see Table 1 ), on the basis of their hyperlipidemic potential. These were screened for their antilipase activity in vitro.
According to the literature survey, except for Alpinia officinarum [9, 10] and Zinziber officinale [11] , none of the other plants had been screened previously for antilipase activity. The models used for the screening of plants in earlier studies were different from those used in our study. Both these plants showed good activity in our assay.
The lipase inhibitory activity of these extracts was calculated as percent inhibition. Table 1 records the inhibitory activity of the tested plants towards pancreatic lipase.
Amongst the screened extracts, 21 showed stronger inhibition potential with percent inhibition values greater than 75%. DCM extracts of G. glabra, S. anacardium and E. prostrata; ethyl acetate extracts of G. glabra and M. koenigii; and methanol extracts of M. koenigii and S. anacardium exhibited antilipase activity greater than 90%, indicating their high potential as sources of natural pancreatic lipase inhibitors. The activity of these extracts was compared with the standard drug orlistat, which NPC Natural Product Communications The inhibitory activity of the plant extracts was weaker than that of the standard drug orlistat. This was expected, as extracts are multi-constituent systems. These extracts can be further fractionated to find out the more potent PL inhibitory compounds. The results suggested that the DCM and ethyl acetate extracts are more active than the respective methanolic extracts. This can be partly explained by the constitution of these extracts. In general, these extracts are rich in flavonoids and terpenes and these types of constituents are expected to be responsible for the stronger activity of the extracts.
M. koenigii, commonly known as 'Curry Patta', is traditionally used in India as a spice for its characteristic flavor and aroma [12] . The aromatic leaves are considered as a tonic, anthelmintic, analgesic, digestive, and appetizer, being widely used in Indian cookery for flavoring food stuffs. The green leaves have been used for the treatment of piles, inflammation, itching, fresh cuts, dysentery, vomiting, burses and dropsy. Aqueous extracts of M. koenigii have a strong hypolipidemic activity and have been indicated for the treatment of the mild form of diabetes, [13] . The aqueous extract of M. koenigii leaves contains a range of active pharmacological agents, including carbazole alkaloids, flavonoids and tannins [14, 15] . In this present study, a phytochemical investigation was made of M. koenigii to find the responsible constituents for the observed activity of the extracts.
Four known carbazole alkaloids mahanimbin (MKE 1), koenimbin (MKE 2), koenigicine (MKE 3) and clausazoline-K (MKE 4) were isolated and identified by comparison of their spectral data with those published in literature [16] [17] [18] [19] [20] [21] .
The isolated compounds were assayed for PL inhibition in vitro and the IC 50 values were determined. The IC 50 values were compared with that of orlistat. Mahanimbin, koenimbin, koenicine and clausazoline-K inhibited PL with IC 50 values of 17.9 µM, 168.6 µM, 428.6 µM and <500 µM, respectively. The higher inhibition by mahanimbin may be associated with its prenylated side chain. Thus prenylated carbazole alkaloids may form the natural template for synthesizing newer PL inhibitors. The study further indicates that the carbazole alkaloids of M. koenigii are major active constituents for the inhibition of PL and thus can be taken as a prototype for developing more potent PL inhibitors for the treatment of obesity. Further in vivo experiments are currently underway in our laboratory to ascertain the effects of M. koenigii alkaloids on lipid metabolism.
Experimental
General: The 1 H NMR and 13 C NMR spectra were recorded on a Bruker DPX-300 instrument. Mass spectra were recorded on a Bruker daltonics Ultraflex MALDI-TOF/TOF instrument. Plants were extracted with a Dionex Accelerated Solvent Extractor. Scanning utilized a Labsystem multiscan microplate reader, while TLC profiling was done on a CAMAG HPTLC instrument. Lipase from porcine pancreas, type II and 4-nitrophenylpalmitate were purchased from Sigma Chemical Co., St. Louis, MO (USA). Solvents used in the extraction were of LR grade and were purchased from Rankem and CDH limited.
Plant materials:
Achyranthes aspera, Aegle marmelose, Asparagus racemosus, Cinnamomum tamala, Eclipta prostrata, Ficus bengalensis, Momordica charantia, M. koenigii, and Terminalia arjuna were collected from the institute campus. The other plant materials were bought from the local market of Chandigarh. The plants were authenticated by the qualified botanist in the medicinal plant garden of NIPER. A collection of voucher specimens is available at the NIPER nursery.
Preparation of plant extracts:
The respective plant materials were dried in an oven at 40 0 C and ground to a coarse powder. The powdered material (50 g) was sequentially extracted with n-hexane, dichloromethane, ethyl acetate and methanol in an Accelerated Solvent Extractor (ASE). The n-hexane extract was discarded and the others were dried in a rotary evaporator and stored under refrigeration conditions.
Isolation of alkaloids from M. koenigii:
Four alkaloids (Figure 1) were isolated from the EtOAc extract of M. koenigii leaves. The extract (10 g) was loaded onto silica gel (# 60-120) and eluted with an increasing gradient of C 6 H 6 : CHCl 3 and then CHCl 3 : CH 3 OH. Five fractions were obtained based on similar TLC patterns. Fraction 2 was purified by prep. TLC to give MKE-1 (94 mg), using C 6 H 6 : CHCl 3 (3:2) as mobile phase. Fraction 6 was further re-chromatographed to yield MKE-2 (20 mg), MKE-3 (35 mg) and MKE-4 (40 mg), respectively.
Screening methodology:
For PL inhibitory activity, the assay procedure [22] was standardized. Lipase activity was measured using 4-nitrophenyl palmitate (PNPP) as a substrate. Porcine PL (Type II, crude) was dissolved in Tris-HCl buffer (pH 8.5) to give a concentration of 1mg/mL. The solution was stored at -20ºC. PNPP was dissolved in acetonitrile to give a stock solution of 10 mM. This was further diluted with ethanol (1:2 v/v) resulting in 3.33 mM PNPP. The solution was stored at -20 0 C. Tris-HCl buffer 0.1 mM was prepared and the pH was adjusted to 8.5 by addition of conc. HCl. Extract solution were prepared by dissolving 1 mg of extract in 1mL of Tris-HCl buffer containing 50 µL of dimethyl sulfoxide. The final 200 μL reaction mixture contained 0.1 mg/mL of porcine PL, 0.167 mM PNPP and 0.25 mg/mL of extract/inhibitor in DMSO. The final volume was adjusted by Tris HCl buffer, pH 8.5. The reaction mixture was incubated at 37 0 C. After incubation for 30 mins, the amount of 4-nitro phenol released by the lipase was measured at 405 nm in a Multiskan microtitre plate reader. All the experiments were performed in triplicate.
